Literature DB >> 18799345

Response inhibition in the stop-signal paradigm.

Frederick Verbruggen1, Gordon D Logan.   

Abstract

Response inhibition is a hallmark of executive control. The concept refers to the suppression of actions that are no longer required or that are inappropriate, which supports flexible and goal-directed behavior in ever-changing environments. The stop-signal paradigm is most suitable for the study of response inhibition in a laboratory setting. The paradigm has become increasingly popular in cognitive psychology, cognitive neuroscience and psychopathology. We review recent findings in the stop-signal literature with the specific aim of demonstrating how each of these different fields contributes to a better understanding of the processes involved in inhibiting a response and monitoring stopping performance, and more generally, discovering how behavior is controlled.

Entities:  

Mesh:

Year:  2008        PMID: 18799345      PMCID: PMC2709177          DOI: 10.1016/j.tics.2008.07.005

Source DB:  PubMed          Journal:  Trends Cogn Sci        ISSN: 1364-6613            Impact factor:   20.229


  73 in total

1.  Performance monitoring by the supplementary eye field.

Authors:  V Stuphorn; T L Taylor; J D Schall
Journal:  Nature       Date:  2000-12-14       Impact factor: 49.962

2.  Don't look! Don't touch! Inhibitory control of eye and hand movements.

Authors:  G D Logan; D E Irwin
Journal:  Psychon Bull Rev       Date:  2000-03

3.  Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans.

Authors:  Adam R Aron; Paul C Fletcher; Ed T Bullmore; Barbara J Sahakian; Trevor W Robbins
Journal:  Nat Neurosci       Date:  2003-02       Impact factor: 24.884

4.  Dissociation of response inhibition and performance monitoring in the stop signal task using event-related fMRI.

Authors:  Andre D Chevrier; Michael D Noseworthy; Russell Schachar
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

5.  Stop the presses: dissociating a selective from a global mechanism for stopping.

Authors:  Adam R Aron; Frederick Verbruggen
Journal:  Psychol Sci       Date:  2008-11

6.  Automatic and controlled response inhibition: associative learning in the go/no-go and stop-signal paradigms.

Authors:  Frederick Verbruggen; Gordon D Logan
Journal:  J Exp Psychol Gen       Date:  2008-11

7.  Proactive adjustments of response strategies in the stop-signal paradigm.

Authors:  Frederick Verbruggen; Gordon D Logan
Journal:  J Exp Psychol Hum Percept Perform       Date:  2009-06       Impact factor: 3.332

8.  Horse-race model simulations of the stop-signal procedure.

Authors:  Guido P H Band; Maurits W van der Molen; Gordon D Logan
Journal:  Acta Psychol (Amst)       Date:  2003-02

9.  Impaired inhibitory control of behavior in chronic cocaine users.

Authors:  Mark T Fillmore; Craig R Rush
Journal:  Drug Alcohol Depend       Date:  2002-05-01       Impact factor: 4.492

10.  On the ability to inhibit thought and action: general and special theories of an act of control.

Authors:  Gordon D Logan; Trisha Van Zandt; Frederick Verbruggen; Eric-Jan Wagenmakers
Journal:  Psychol Rev       Date:  2014-01       Impact factor: 8.934

View more
  359 in total

1.  Pinning down response inhibition in the brain--conjunction analyses of the Stop-signal task.

Authors:  C N Boehler; L G Appelbaum; R M Krebs; J M Hopf; M G Woldorff
Journal:  Neuroimage       Date:  2010-05-07       Impact factor: 6.556

2.  The role of the right presupplementary motor area in stopping action: two studies with event-related transcranial magnetic stimulation.

Authors:  Weidong Cai; Jobi S George; Frederick Verbruggen; Christopher D Chambers; Adam R Aron
Journal:  J Neurophysiol       Date:  2012-04-18       Impact factor: 2.714

3.  Event-related potentials elicited by errors during the stop-signal task. II: human effector-specific error responses.

Authors:  Robert M G Reinhart; Nancy B Carlisle; Min-Suk Kang; Geoffrey F Woodman
Journal:  J Neurophysiol       Date:  2012-02-22       Impact factor: 2.714

4.  Expectations and violations: delineating the neural network of proactive inhibitory control.

Authors:  Bram B Zandbelt; Mirjam Bloemendaal; Sebastiaan F W Neggers; René S Kahn; Matthijs Vink
Journal:  Hum Brain Mapp       Date:  2012-02-22       Impact factor: 5.038

5.  Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity.

Authors:  Alexandra S Potter; David J Bucci; Paul A Newhouse
Journal:  Psychopharmacology (Berl)       Date:  2011-10-04       Impact factor: 4.530

6.  Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans.

Authors:  Dara G Ghahremani; Buyean Lee; Chelsea L Robertson; Golnaz Tabibnia; Andrew T Morgan; Natalie De Shetler; Amira K Brown; John R Monterosso; Adam R Aron; Mark A Mandelkern; Russell A Poldrack; Edythe D London
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

7.  Performance monitoring local field potentials in the medial frontal cortex of primates: supplementary eye field.

Authors:  Erik E Emeric; Melanie Leslie; Pierre Pouget; Jeffrey D Schall
Journal:  J Neurophysiol       Date:  2010-07-21       Impact factor: 2.714

8.  When response inhibition is followed by response reengagement: an event-related fMRI study.

Authors:  Maren Boecker; Barbara Drueke; Verena Vorhold; Andre Knops; Bernd Philippen; Siegfried Gauggel
Journal:  Hum Brain Mapp       Date:  2011-01       Impact factor: 5.038

9.  Response inhibition and response monitoring in a saccadic double-step task in schizophrenia.

Authors:  Katharine N Thakkar; Jeffrey D Schall; Gordon D Logan; Sohee Park
Journal:  Brain Cogn       Date:  2015-03-10       Impact factor: 2.310

10.  Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.

Authors:  David S Jacobs; Stephen J Kohut; Shan Jiang; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman
Journal:  Exp Clin Psychopharmacol       Date:  2016-08-15       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.